PCRX Cost of Revenue
Pacira Biosciences Inc · Cost of Revenue
PCRX Cost of Revenue
Latest reported$155.15Mperiod ending
PCRX Cost of Revenue ($17.46M → $155.15M)
Annual cost of revenue
High-resolution chart · PNG
PCRX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 149,749,000 | |
| 170,428,000 | |
| 184,669,000 | |
| 199,295,000 | |
| 140,255,000 | |
| 117,328,000 | |
| 106,712,000 | |
| 86,845,000 | |
| 87,915,000 | |
| 110,104,000 | |
| 71,837,000 | |
| 77,440,000 | |
| 54,772,000 | |
| 32,139,000 | |
| 16,739,000 | |
| 12,276,000 | |
| 12,301,000 | |
| 17,463,000 |